logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/03/2026
Pfizer: The phase II clinical trial results of the new generation CDK4 inhibitor palbociclib as a second-line treatment for metastatic breast cancer are promising.
Latest
4 m ago
*ST Xingnong received the "preliminary notice of administrative penalty" from the Zhejiang Securities Regulatory Bureau*
4 m ago
Express news before the US stock market opens
6 m ago
Mackenzie predicts that the Federal Reserve will raise interest rates in the first half of 2027, instead of the previously forecasted fourth quarter of 2026.
7 m ago
Robotech: Subsidiary signs about 48 million yuan double-sided wafer testing equipment and service mass production order
7 m ago
Helen Che: Shareholders holding more than 5% of the shares completed a plan to increase their holdings by 35,000,100 shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.